Olivia Hull
Medical Oncology · Opelika, ALNPI 1841634789
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.9% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $688 and has fallen 97.5% since, to $17 in 2025. That places this record below the midpoint for medical oncology clinicians in AL, where the typical reported total is $5,924.
Across 61 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$217
- Amgen$137
- Pfizer$108
- Gilead$88
- AstraZeneca$56
- Sanofi$50
- plus $397 from 16 others
What the payments were for
- Food & beverage$96792%
- Education$858%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 16 | $217 |
| Amgen | 7 | $137 |
| Pfizer | 6 | $108 |
| Gilead(2 entities) | 6 | $88 |
| AstraZeneca | 3 | $56 |
| Sanofi | 2 | $50 |
| AbbVie | 2 | $48 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $48 |
| Astellas Pharma US Inc | 3 | $47 |
| Exelixis Inc. | 1 | $41 |
| Seagen Inc. | 2 | $31 |
| Servier Pharmaceuticals LLC | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $23 |
| Morphosys, US Inc. | 1 | $20 |
| Novartis | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Mirati Therapeutics, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| GSK | 1 | $13 |
| Myovant Sciences Inc. | 1 | $12 |
| Epizyme, Inc. | 1 | $12 |
How this compares
$1,053 in reported general payments places this provider in the 15th percentile of 30 medical oncology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 11 | $293 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Opelika
- Joelle HamiltonHomewood$361K
- Syed Abbas AliJasper$51K
- Pranitha ProdduturvarMobile$33K
- Johnny NacillaCullman$23K
- Michael GarciaJasper$23K
- John WaplesHuntsville$19K
- Susan BostickTuscaloosa$17K
- Brittany CaseDaphne$17K
- Charles LattuadaAnniston$16K
- David HintonTuscaloosa$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.